Purchase of two (2) emulate ZOE CM1 and one (1) ORB hub module-1 organ-on-a-chip culture modules
Ended Purchase Order Awarded
- Contract number
- 75F40125P00193
- Awardee
-
Emulate Inc. UEI RPUADLQ52GD7
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $45,000
Award facts
- Contract value 100% obligated
- $45,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a purchase order to Emulate Inc. for $45,000 on August 28, 2025, for the procurement of organ-on-chip culture modules, specifically two Emulate Zoe CM1 units and one Orb Hub Module-1. The contract is structured as a firm fixed-price purchase order with an ultimate completion date of August 28, 2026, and performance will take place at the FDA's facility in Silver Spring, Maryland. No set-aside designation was used for this award.
Emulate Inc., a Boston-based biotechnology company specializing in microphysiological systems and organ-on-chip technology, serves as the prime contractor on this procurement. The company develops bioengineered systems that replicate human organ functions to support advanced research initiatives, offering researchers an innovative alternative to traditional testing methods. This purchase order supports the FDA's regulatory science mission by providing sophisticated hardware solutions that enable more accurate modeling of human biology, contributing to the agency's efforts in drug development screening and non-animal testing approaches. The award reflects the FDA's continued investment in Emulate's organ-chip technology platforms for research applications within the Department of Health and Human Services.
Quick answers
Who was awarded contract 75F40125P00193?
75F40125P00193 was awarded to Emulate Inc. by Food and Drug Administration (Department of Health and Human Services) on August 28, 2025.
How much is contract 75F40125P00193 worth?
The government has obligated $45,000 on 75F40125P00193.
Was contract 75F40125P00193 competed?
The extent of competition for 75F40125P00193 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award